Breast Cancer
New findings in breast cancer described from Italy, the United Kingdom and the United States
Published in Obesity and Diabetes Week, October 30th, 2006
Study 1: Exemestane after tamoxifen therapy may be associated with positive body composition changes in postmenopausal women.
According to a study published in the British Journal of Cancer, "Recent studies have shown that administering the aromatase inhibitor exemestane after 2-3 years of tamoxifen therapy significantly improves disease-free survival in postmenopausal women with primary breast cancer in comparison with standard 5-year tamoxifen treatment. Although many of the adverse effects associated with exemestane and tamoxifen have been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Adipocyte
In rat adipocytes, AICAR-induced AMPK phosphorylation inhibits insulin-stimulated glucose uptake - Diet & Nutrition
Hydroxycitrate attenuates body weight and visceral fat, but leads to accumulation of liver lipids - Obesity Complications
Conjugated linoleic acids do not affect lipoprotein profile in overweight with LDL phenotype B - Obesity Epidemiology
Meal size, not body size, explains errors in estimating the calorie content of meals - Renal Function
Obese hypertensives lose renal reserve earlier in renal dysfunction evolution - Obesity and Diabetes
Center for Molecular and Vascular Biology describes research in obesity and diabetes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
